Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
NCT04022616 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 99
Last updated 2026-04-06
Summary
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
Conditions
Interventions
- OTHER
-
Specimen collection
Specimens are obtained from patients who are being treated for breast malignancies.
Sponsors & Collaborators
-
Ohio State University Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
William Carson, MD · Ohio State Comprehensive Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-06-04
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
Isolation and Characterization of Mammary Stem Cells
NCT00340392 ·Status: COMPLETED
-
Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer
NCT06918262 ·Status: RECRUITING
-
A Study of Effect of Megakaryocytes and Platelets in Breast Cancer
NCT06011824 ·Status: COMPLETED
-
Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer Survivors
NCT01627366 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients
NCT00355316 ·Status: COMPLETED ·Phase: NA
-
Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients
NCT01305954 ·Status: COMPLETED
-
Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality
NCT01024114 ·Status: WITHDRAWN
-
The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer
NCT01023802 ·Status: COMPLETED
-
Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage
NCT00156260 ·Status: TERMINATED
-
Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers
NCT00225927 ·Status: COMPLETED ·Phase: NA
-
Breast Cancer Survivorship Biorepository
NCT05786664 ·Status: RECRUITING
-
Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer
NCT00276120 ·Status: COMPLETED
-
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
NCT01286233 ·Status: UNKNOWN
-
Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer
NCT00493350 ·Status: COMPLETED
-
Screening in Myocardial Perfusion Patients
NCT00943241 ·Status: COMPLETED
-
Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer
NCT00923377 ·Status: COMPLETED
-
Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer
NCT00588029 ·Status: ACTIVE_NOT_RECRUITING
-
Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
NCT04021069 ·Status: UNKNOWN
-
Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations
NCT05264532 ·Status: COMPLETED ·Phase: NA
-
New Technique as an Additional Diagnostic Tool for Women Undergoing Neoadjuvant Therapy for Breast Cancer
NCT00566085 ·Status: COMPLETED ·Phase: NA
-
The Detection of Cell-in-cell Structure (CICs) in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy
NCT05642104 ·Status: UNKNOWN
-
Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer
NCT00323908 ·Status: COMPLETED
-
MRD in High-risk EBC
NCT06566729 ·Status: ACTIVE_NOT_RECRUITING
-
Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
NCT05804578 ·Status: RECRUITING
-
A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer
NCT04655573 ·Status: TERMINATED